Geneticure
Pharmacogenomic tests to control large, chronic diseases faster than trial/error.
Launch date
Employees
Market cap
-
Enterprise valuation
€909k—1m (Dealroom.co estimates Oct 2016.)
Minneapolis Minnesota (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$870k | Seed | ||
N/A | $250k | Seed | |
N/A | $500k | Seed | |
N/A | $1.0m | Seed | |
N/A | $1.7m | Seed | |
Total Funding | €3.9m |
Related Content
Recent News about Geneticure
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.